Presentation slides and video from the 2017 Advances in Cancer Immunotherapy™ - Houston, TX held on December 2, 2017 are available here.Program Organizers
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Basic Principles of Cancer Immunotherapy; Presenter: Michael Curran, PhD - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:33:42
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice: Presentation: Coverage and Reimbursement Challenges and Strategies; Presenter: Jeff Liticker, R.Ph, PharmD, BCOP - UT Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center; Date: December 2, 201700:32:35
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice: Presentation: Effective Practices for Incorporating Immunotherapy into Hospital Operations; Presenter: Jeff Liticker, R.Ph, PharmD, BCOP - UT Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center; Date: December 2, 201700:34:23
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Identification and Management of Immune-Related Adverse Events in the Emergency Setting; Presenter: Monica Wattana, MD, FAAEM - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:35:43
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Genitourinary Cancer; Presenter: Jianjun Gao, Md, PhD - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:25:47
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Hematologic Malignancies; Presenter: Sattva S. Neelapu, MD - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:23:45
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Head and Neck Cancers; Presenter: Renata Ferrarotto, MD - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:17:46
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Melanoma; Presenter: Isabella C. Glitza, MD, PhD - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:27:17
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Management and Mitigation of irAEs for Immunotherapy Prescribers; Presenter: Aung Naing, MD - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:19:15
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Mechanisms of Immune-Related Adverse Events; Presenter: Sang Kim, MD, PhD - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:21:16
Meeting: Advances in Cancer Immunotherapy™- Houston, TX; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Nursing Perspective on irAEs: Patient Education, Monitoring and Management; Presenter: Michelle Rohlfs, RN, FNP-BC, AOCNP - University of Texas MD Anderson Cancer Center; Date: December 2, 201700:34:18
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us